Qarziba 4.5 mg/mL concentrate for solution for infusion
ChIm-NB-PL
Phase 3 small_molecule active
Quick answer
Qarziba 4.5 mg/mL concentrate for solution for infusion for Recurrent or progression of neuroblastoma or neuroblastoma or neuroblastoma refractory to first-line treatment. is a Phase 3 program (small_molecule) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- COLLEGIUM PHARMACEUTICAL, INC
- Indication
- Recurrent or progression of neuroblastoma or neuroblastoma or neuroblastoma refractory to first-line treatment.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active